Substance P receptor antagonists in the therapy of migraine

Expert Opinion on Investigational Drugs
A May, P J Goadsby

Abstract

Clinical observations, the vascular component of migraine pain, its pulsating or throbbing pain character, have focused attention on the trigeminal innervation of pain-sensitive intracranial structures, such as the dura mater and large vessels. These intracranial structures are innervated by the ophthalmic branch of the trigeminal nerve, which is marked by the presence of vasoactive peptides, such as substance P and calcitonin gene-related peptide. Substance P is a mediator of the sterile inflammation of the dura mater, which has been considered to be the source of migraine pain. Modern antimigraine drugs, such as 5-HT(1B/D) agonists (triptans), block this dural neurogenic inflammation dose-dependently in an animal model but their vasoconstrictor effects have led to a search for non-vasoconstrictor approaches. One such approach has been substance P (neurokinin-1) antagonists. These are highly effective in animal models of dural inflammation and have no significant vasoconstrictive effect. However, several NK(1) antagonists failed to demonstrate any effect in acute migraine. Current clinical and experimental evidence therefore supports the view that NK(1) receptor antagonists may have no significant antimigraine properties.

References

Oct 1, 1979·British Journal of Pharmacology·W FeniukA D Watts
Aug 1, 1992·Trends in Pharmacological Sciences·M A Moskowitz
Mar 1, 1988·Cephalalgia : an International Journal of Headache·F SorgeP Carrieri
Aug 1, 1984·Annals of Neurology·M A Moskowitz
Jan 1, 1995·Cephalalgia : an International Journal of Headache·L Edvinsson, P J Goadsby
Feb 1, 1993·Cephalalgia : an International Journal of Headache·E BeskenG Sartory
Jul 1, 1995·Canadian Journal of Physiology and Pharmacology·D T BeattieR M Hagan
Oct 1, 1996·Cephalalgia : an International Journal of Headache·P J Goadsby, L Edvinsson
Oct 1, 1996·Experimental Brain Research·J CarmodyK Messlinger
Oct 1, 1996·Brain : a Journal of Neurology·K L HoskinP J Goadsby
May 1, 1997·Cephalalgia : an International Journal of Headache·H E ConnorP P Humphrey
Jun 5, 1997·European Journal of Pharmacology·D J WilliamsonR J Hargreaves
Dec 17, 1997·Cephalalgia : an International Journal of Headache·D J GoldsteinN T Mathew
Dec 2, 1998·Clinical Pharmacology and Therapeutics·R A DionneD B MacLean

❮ Previous
Next ❯

Citations

Mar 17, 2009·Experimental Brain Research·Karl Messlinger
Apr 24, 2007·Cephalalgia : an International Journal of Headache·Nicola MorelliLuigi Murri
May 24, 2008·Cephalalgia : an International Journal of Headache·G Martino, M N Perkins
May 11, 2006·Cerebrovascular Diseases·B Piechowski-JozwiakJ Bogousslavsky
Nov 18, 2009·BMC Medicine·Till Sprenger, Peter J Goadsby
Oct 8, 2011·The Keio Journal of Medicine·Karl MesslingerJochen K Lennerz
Apr 3, 2014·Iranian Red Crescent Medical Journal·Yu-Feng ShaoYi-Ping Hou
Nov 4, 2015·Toxins·Min HouYi-Ping Hou
Aug 31, 2006·Expert Opinion on Emerging Drugs·Peter J Goadsby
Nov 30, 2002·Expert Opinion on Investigational Drugs·Hermann Mucke
Sep 4, 2012·Pharmacology & Therapeutics·Lars EdvinssonAntoinette MaassenVanDenBrink
Jan 12, 2016·Progress in Neurobiology·Henrik SchytzMessoud Ashina
Dec 5, 2006·Trends in Molecular Medicine·Peter J Goadsby
Sep 29, 2006·The European Journal of Neuroscience·A BergerotP J Goadsby
Sep 17, 2013·Journal of Veterinary Internal Medicine·I N PlessasP J Kenny
Jan 18, 2014·Headache·Karl B Alstadhaug
Apr 28, 2004·Bioorganic & Medicinal Chemistry·Cyrus J OhnmachtDavid Aharony
Jun 22, 2015·Neuropeptides·János TajtiLászló Vécsei
Nov 1, 2003·Expert Review of Neurotherapeutics·Jonathan P Gladstone, David W Dodick
Apr 28, 2005·Expert Review of Neurotherapeutics·Paola Sarchielli, Virgilio Gallai
Mar 30, 2016·Current Opinion in Neurology·Andrew Charles, Amynah A Pradhan
Sep 9, 2016·Annals of Clinical and Translational Neurology·Maggie W WaungPeter J Goadsby
Oct 14, 2016·JCI Insight·Ehsan AzimiEthan A Lerner
Jan 6, 2017·Nature Reviews. Cardiology·Ehsan Azimi, Ethan A Lerner
Jul 6, 2017·Cephalalgia : an International Journal of Headache·Clara DomínguezRogelio Leira
Mar 29, 2003·Cephalalgia : an International Journal of Headache·H-C Diener, UNKNOWN RPR100893 Study Group
Oct 11, 2017·Antioxidants & Redox Signaling·Patrizia FerroniFiorella Guadagni
May 15, 2018·Headache·Joshua Kamins, Andrew Charles
Mar 12, 2008·The Neurologist·Rukmini Menon, Cheryl D Bushnell
Apr 16, 2019·Headache·Smriti IyengarSheena K Aurora
Apr 19, 2018·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Peter J Goadsby, Philip R Holland
Jul 3, 2019·Nature Reviews. Neurology·Lars EdvinssonKarin Warfvinge
Jan 20, 2018·Neurological Research·Piet Borgdorff
Feb 10, 2017·Physiological Reviews·Peter J GoadsbySimon Akerman
Nov 17, 2009·Cephalalgia : an International Journal of Headache·R J StorerP J Goadsby
Aug 30, 2019·The Journal of Headache and Pain·Andrea M HarriottPhilip R Holland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.